Sunshine Guojian Pharmaceutical Shanghai (SHA:688336) appointed Niu Hongmei as chief financial officer to succeed Sun Yongzhi, who resigned due to a job transfer.
Niu joined the drugmaker as financial manager in June 2017, according to a Wednesday filing with the Shanghai bourse.
Sun continues to serve as a director of Sunshine Guojian Pharmaceutical Shanghai.
Shares of the company closed 1% lower Wednesday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.